You have 9 free searches left this month | for more free features.

GVHD.

Showing 2326 - 2346 of 2,346

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pilot Study: Effects of G-CSF on T Cell Function

Completed
  • Healthy
    • Bethesda, Maryland
      Warren G. Magnuson Clinical Center (CC)
    Mar 3, 2008

    Peripheral Blood Lymphocytes and Marrow Progenitor Cells From

    Completed
    • Chronic Myeloid Leukemia
    • +3 more
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Mar 3, 2008

      Sjogren's Syndrome, Xerostomia Trial run by the NIDCR (Thalidomide)

      Completed
      • Sjogren's Syndrome
      • Xerostomia
      • Bethesda, Maryland
        National Institute of Dental And Craniofacial Research (NIDCR)
      Mar 3, 2008

      Hematologic Tumor, HIV Infection Trial run by the NIDDK (GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV)

      Completed
      • Hematologic Neoplasm
      • HIV Infection
      • GCSF Mobilized Allogeneic PBSC Cultured w/Cytokines; Transduced w/RV
      • Bethesda, Maryland
        National Institute of Diabetes and Digestive and Kidney Diseases
      Mar 3, 2008

      Assessment of Regulatory Immune Cell Populations After

      Unknown status
      • Allogeneic Hematopoietic Cell Transplant Recipients
        • Vienna, Austria
        • +1 more
        Jan 4, 2008

        Hematological Malignancies Trial in Perugia (Thymosin alpha 1)

        Unknown status
        • Hematological Malignancies
        • Thymosin alpha 1
        • Perugia, Italy
          Hematology Section, University of Perugia
        Dec 21, 2007

        Low Dose Irradiation for Small Bowel Transplant

        Completed
        • Irreversible Intestinal Failure
        • Allograft Rejection
        • Reduce the risk of allograft rejection
        • Pittsburgh, Pennsylvania
          University of Pittsburgh Medical Center
        Dec 13, 2007

        Chronic Granulomatous Disease Trial run by the NIAID (T-Cell Depleted & CD34+Select/w/StemCell Enriched Product)

        Completed
        • Chronic Granulomatous Disease
        • T-Cell Depleted & CD34+Select/w/StemCell Enriched Product
        • Bethesda, Maryland
          National Institute of Allergy and Infectious Diseases (NIAID)
        Mar 3, 2008

        Graft-vs-Host Disease (GVHD) Trial in Navarra, Barcelona, Salamanca (Mesenchymal stem cell (MSC))

        Unknown status
        • Graft-vs-Host Disease (GVHD)
        • Mesenchymal stem cell (MSC)
        • Navarra, Pamplona, Spain
        • +3 more
        Mar 20, 2007

        GVHD Trial in Vellore (Mesenchymal Stem Cell Infusion)

        Unknown status
        • Graft vs Host Disease
        • Mesenchymal Stem Cell Infusion
        • Vellore, Tamil Nadu, India
          Department of Haematology, Christian Medical College
        Jul 3, 2007

        GVHD Trial in Tunis (filgrastim)

        Unknown status
        • Graft vs Host Disease
        • Tunis, Tunisia
          Centre National de Greffe de Moelle Osseuse
        Nov 5, 2007

        Leukocyte-Adhesion Deficiency Syndrome Trial run by the NIAID (modified stem cell transplant)

        Completed
        • Leukocyte-Adhesion Deficiency Syndrome
        • modified stem cell transplant
        • Bethesda, Maryland
          National Institute of Allergy and Infectious Diseases (NIAID)
        Mar 3, 2008

        GVHD Trial in Jerusalem (intra-arterial treatment)

        Completed
        • Graft vs Host Disease
        • intra-arterial treatment
        • Jerusalem, Israel
          Hadassah Medical Organization
        Nov 6, 2006

        GVHD, Multiple Myeloma Trial run by the NCI (Myeloma Immunoglobulin Idiotype Vaccine-KLH, GM-CSF)

        Completed
        • Graft vs Host Disease
        • Multiple Myeloma
        • Myeloma Immunoglobulin Idiotype Vaccine-KLH
        • GM-CSF
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Sep 21, 2007

        Bone Marrow Transplantation, GVHD, GVHD Trial in Japan (Tacrolimus)

        Completed
        • Bone Marrow Transplantation
        • +3 more
        • Chubu region, Japan
        • +3 more
        Sep 19, 2006

        Leukemia, Lymphoma, Low-Grade, Lymphoma, Non-Hodgkin's Trial in Ann Arbor (Reduced intensity conditioning, Prophylactic donor

        Terminated
        • Leukemia
        • +4 more
        • Reduced intensity conditioning
        • Prophylactic donor leukocyte infusions
        • Ann Arbor, Michigan
          The University of Michigan
        Apr 20, 2007

        Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Denver (Cord Blood Transplant)

        Unknown status
        • Acute Myeloid Leukemia
        • +4 more
        • Cord Blood Transplant
        • Denver, Colorado
          Rocky Mountain Blood and Marrow Transplant Program
        Jun 23, 2006

        Graft Vs Host Disease, Gastrointestinal GVHD Trial in Seattle (Oral beclomethasone dipropionate (drug))

        Completed
        • Graft Vs Host Disease
        • Gastrointestinal Graft-Versus-Host Disease
        • Oral beclomethasone dipropionate (drug)
        • Seattle, Washington
          Fred Hutchinson Cancer Research Center
        Oct 4, 2005

        Graft Vs Host Disease Trial in Jerusalem (Budesonide)

        Completed
        • Graft Vs Host Disease
        • Jerusalem, Israel
          Hadassah Medical Organization,
        Aug 26, 2005

        Thrombocytopenia, Metachromatic Leukodystrophy, Fanconi's Anemia Trial in Los Angeles (Stem Cell Transplantation)

        Completed
        • Thrombocytopenia
        • +5 more
        • Stem Cell Transplantation
        • Los Angeles, California
          University of California Los Angeles Medical Center
        Jun 23, 2005

        Graft-vs-Host Disease Trial in United States (Visilizumab)

        Unknown status
        • Graft-vs-Host Disease
        • Duarte, California
        • +16 more
        Jun 23, 2005